XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Stock Information for Gamida Cell Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Gamida Cell Ltd.

XORTX Provides Update on FDA Type B Meeting Request
XORTX Announces Grant of European Patent
XORTX Announces Update for Discussion with the FDA
XORTX Commences Gout Program NDA Discussions with the FDA
XORTX to Present at Microcap Conference
XORTX Announces Change of Auditor
XORTX Adds Late Stage Gout Program to Pipeline
XORTX Strengthens Executive Team

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.